GlassScriptPhysician profile
Katrina Carter
NPI 1013994102
$1,372.38
in general payments reported to CMS, 2019-2025
22 companies · $365 in 2025
The $365 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $492 · 2021: $384 · 2022: $132 · 2025: $365.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $365.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $320.73 | 2020-2025 | |
| Eisai INC. | $140.65 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $89.26 | 2021 | |
| Upsher-Smith Laboratories LLC | $85.10 | 2020-2021 | |
| Lilly USA, LLC | $79.92 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $69.36 | 2025 | Relistor |
| Vertex Pharmaceuticals Incorporated | $60.28 | 2025 | |
| Merz Pharmaceuticals, LLC | $54.80 | 2025 | Xeomin |
| Amgen INC. | $53.02 | 2020 | |
| Protega Pharmaceutials INC | $50.76 | 2025 | Roxybond |
| Takeda Pharmaceuticals U.S.A., INC. | $48.71 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $47.16 | 2020-2021 | |
| Astrazeneca Pharmaceuticals LP | $39.98 | 2020 | |
| Collegium Pharmaceutical, INC. | $35.85 | 2025 | Xtampza |
| Arbor Pharmaceuticals, INC. | $35.66 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $32.97 | 2025 | Movantik |
| Pfizer INC. | $29.19 | 2020-2025 | |
| Biohaven Pharmaceuticals, INC. | $23.49 | 2021 | |
| Alnylam Pharmaceuticals INC. | $21.34 | 2020 | |
| Bausch Health US, LLC | $20.02 | 2021 | |
| Boston Scientific Corporation | $19.00 | 2021 | |
| Therapeuticsmd, INC. | $15.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katrina Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.